Carmen L. Ospina Salazar

Author

Also Known As

Carmen L O Salazar, Carmen L Ospina Salazar, Carmen L. Ospina Salazar, Carmen L. Salazar, Carmen Lucelly Ospina Salazar, Carmen Rosal-Fraga, Carmen L. Ospina Salazar, Harlem Madrid, Nuria Rodriguez-Prado

Publications

768

Citations

H-Index

Concepts

All Affiliations

University of Tübingen Albert Schweitzer Hospital Sanofi (France)Université des Sciences de la Santé Centre de Recherche Médicales de Lambaréné

About

Carmen L. Ospina Salazar is an author at University of Tübingen specializing in malaria, medicine, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	286
2	Public Health	2	2	196
3	Epidemiology	2	2	196
4	Global Health	2	2	196
5	Pharmacology	1	1	90

Carmen L. Ospina Salazar

Publications

648

Citations

H-Index

Page 1

	Year	Citations
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres Benjamin Mordmüller, Christian Supan, Kim Lee Sim, Malaria Journal	2015	135
High Prevalence of Asymptomatic Plasmodium falciparum Infection in Gabonese Adults Matthias P. Dal-Bianco, Kai B. Köster, U.D. Kombila, American Journal of Tropical Medicine and Hygiene Parasitic DiseaseGlobal HealthMalariaPathogenesisDiagnosis	2007	108
Intermittent Preventive Treatment against Malaria in Infants in Gabon—A Randomized, Double‐Blind, Placebo‐Controlled Trial Martin P. Grobusch, Bertrand Lell, Norbert Georg Schwarz, The Journal of Infectious Diseases	2007	93
Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections Christian Supan, Ghyslain Mombo‐Ngoma, Matthias P. Dal-Bianco, Antimicrobial Agents and Chemotherapy Ferrocene-quinoline ConjugatePharmaceutical ScienceAntiparasitic AgentMalariaPharmacotherapy	2012	90
Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study Jana Held, Christian Supan, Carmen L. Ospina Salazar, The Lancet Infectious Diseases Global HealthMalariaClinical EpidemiologyAfrican AdultsPlasmodium Falciparum Malaria	2015	88
Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection Ghyslain Mombo‐Ngoma, Christian Supan, Matthias P. Dal-Bianco, Malaria Journal	2011	73
Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria Christian Supan, Ghyslain Mombo‐Ngoma, Maryvonne Kombila, American Journal of Tropical Medicine and Hygiene	2017	29
Sporozoite Route of Infection Influences In Vitro<i>var</i>Gene Transcription of<i>Plasmodium falciparum</i>Parasites From Controlled Human Infections Sandra Dimonte, Ellen Bruske, Christian Supan, The Journal of Infectious Diseases	2016	21
Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients Jana Held, Christian Supan, Carmen L. Ospina Salazar, Malaria Journal	2017	11

Page 1